{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:17:57Z","timestamp":1776122277576,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.conctc.2019.100393","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T02:04:48Z","timestamp":1559959488000},"page":"100393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study"],"prefix":"10.1016","volume":"15","author":[{"given":"Milica","family":"Bajcetic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia N.","family":"de Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"Dalinghaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Breitkreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Klingmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian B.","family":"Lagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Keatley-Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes MPJ.","family":"Breur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Male","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andras","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Ablonczy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjoern B.","family":"Burckhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willi","family":"Cawello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Kleine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emina","family":"Obarcanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Spatenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijke","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"L\u00e4er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.conctc.2019.100393_bib1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9149(87)91118-0","article-title":"Plasma norepinephrine levels in infants and children with congestive heart failure","volume":"59","author":"Ross","year":"1987","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.conctc.2019.100393_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1058-9813(00)00055-2","article-title":"Overview of the management of pediatric heart failure","volume":"11","author":"Auslender","year":"2000","journal-title":"Prog. Pediatr. Cardiol."},{"key":"10.1016\/j.conctc.2019.100393_bib3","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.healun.2014.06.002","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary","volume":"33","author":"Kirk","year":"2014","journal-title":"J. Heart Lung Transplant."},{"issue":"7","key":"10.1016\/j.conctc.2019.100393_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00059-005-2596-6","article-title":"Congestive Heart Failure in Childhood. An Epidemiologic Study; Herzinsuffizienz im Kindesalter. Eine epidemiologische Studie","volume":"30","author":"Sommers","year":"2005","journal-title":"Herz"},{"issue":"8","key":"10.1016\/j.conctc.2019.100393_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/clc.20262","article-title":"Epidemiology of heart failure in a tertiary pediatric center","volume":"31","author":"Massin","year":"2008","journal-title":"Clin. Cardiol."},{"issue":"6","key":"10.1016\/j.conctc.2019.100393_bib6","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCRESAHA.116.308996","article-title":"Heart failure in pediatric patients with congenital heart disease","volume":"120","author":"Hinton","year":"2017","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.conctc.2019.100393_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCULATIONAHA.106.671735","article-title":"New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland","volume":"117","author":"Andrews","year":"2008","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.conctc.2019.100393_bib8","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jacc.2013.05.020","article-title":"ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.conctc.2019.100393_bib9","series-title":"Committee for Proprietary Medicinal Products (CPMP) Summary Information of Referral Opinion Pursuant to Article 30 of Council Directive 2001\/83\/EC for Renitec and Associated Names (See Annex I), London 4 December 2003","author":"EMA","year":"2003"},{"issue":"3","key":"10.1016\/j.conctc.2019.100393_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/hrt.54.3.305","article-title":"Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state","volume":"54","author":"Cleland","year":"1985","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.conctc.2019.100393_bib11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"Hunt","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.conctc.2019.100393_bib12","series-title":"Report on the Expert Group Meeting of Paediatric Heart Failure, London 29 November 2010","author":"EMA","year":"2010"},{"issue":"4","key":"10.1016\/j.conctc.2019.100393_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-3476(89)80715-2","article-title":"Orally administered enalapril for infants with congestive heart failure: a dose-finding study","volume":"114","author":"Lloyd","year":"1989","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.conctc.2019.100393_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/clpt.1994.119","article-title":"The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure","volume":"56","author":"Nakamura","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.conctc.2019.100393_bib15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1177\/00912700122012661","article-title":"The pharmacokinetics of enalapril in children and infants with hypertension","volume":"41","author":"Wells","year":"2001","journal-title":"J. Clin. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.conctc.2019.100393_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2018.02.037","article-title":"Flexible and precise dosing of enalapril maleate for all paediatric age groups utilizing orodispersible minitablets","volume":"541","author":"Thabet","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.conctc.2019.100393_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2147\/DDDT.S188417","article-title":"On behalf of the LENA consortium. Model-dependent pharmacokinetic analysis of enalapril administered to healthy adult volunteers using orodispersible mini-tablets for use in paediatrics","volume":"13","author":"Faisal","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"issue":"6","key":"10.1016\/j.conctc.2019.100393_bib18","first-page":"431","article-title":"Tailored assays for pharmacokinetic and pharmacodynamic investigations of aliskiren and enalapril in children: an application in serum, urine, and saliva","volume":"20","author":"Burckhardt","year":"2015","journal-title":"J. Pediatr. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.conctc.2019.100393_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/FJC.0b013e3182676f06.","article-title":"An integrated physiology-based model for the interaction of RAA system biomarkers with drugs","volume":"60","author":"Ramusovic","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.conctc.2019.100393_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/bmc.1716","article-title":"Determination of enalapril and enalaprilat in small human serum quantities for pediatric trials by HPLC-tandem mass spectrometry","volume":"26","author":"Ramusovic","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.conctc.2019.100393_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.plabm.2017.07.004","article-title":"Validated low-volume aldosterone immunoassay tailored to GCLP-compliant investigations in small sample volumes","volume":"27","author":"Schaefer","year":"2017","journal-title":"Pract. Lab. Med."},{"issue":"6","key":"10.1016\/j.conctc.2019.100393_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/15321819.2017.1350707","article-title":"Validated low-volume immunoassay for the reliable determination of direct renin especially valuable for pediatric investigations","volume":"38","author":"Schaefer","year":"2017","journal-title":"J. Immunoass. Immunochem."},{"issue":"4","key":"10.1016\/j.conctc.2019.100393_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10557-017-6733-2","article-title":"The pharmacogenomic and metabolomic predictors of ACE inhibitor and angiotensin II receptor blocker effectiveness and safety","volume":"31","author":"Flaten","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"8","key":"10.1016\/j.conctc.2019.100393_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/009127002401102786","article-title":"For the Enalapril Pediatric Hypertension Collaborative Study Group. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension","volume":"42","author":"Wells","year":"2002","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.conctc.2019.100393_bib25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1515\/JPM.2008.064","article-title":"Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants","volume":"36","author":"Gantenbein","year":"2008","journal-title":"J. Perinat. Med."},{"issue":"3","key":"10.1016\/j.conctc.2019.100393_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00246-013-0813-2","article-title":"Angiotensin-converting enzyme inhibitor nephrotoxicity in neonates with cardiac disease","volume":"35","author":"Lindle","year":"2014","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.conctc.2019.100393_bib27","series-title":"Guideline on Pharmaceutical Development of Medicines for Paediatric Use. EMA\/CHMP\/QWP\/805880\/2012 Rev. 2; 2013","author":"EMA","year":"2013"},{"issue":"3","key":"10.1016\/j.conctc.2019.100393_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/archdischild-2011-300958","article-title":"Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study","volume":"97","author":"Spomer","year":"2012","journal-title":"Arch. Dis. Child."},{"issue":"6","key":"10.1016\/j.conctc.2019.100393_bib29","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jpeds.2013.07.014","article-title":"Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children","volume":"163","author":"Klingmann","year":"2013","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.conctc.2019.100393_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jpeds.2015.07.010","article-title":"Acceptability of uncoated mini-tablets in neonates\u2014a randomized controlled trial","volume":"167","author":"Klingmann","year":"2015","journal-title":"J. Pediatr."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865419300456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865419300456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:06:42Z","timestamp":1762520802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865419300456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":30,"alternative-id":["S2451865419300456"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2019.100393","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2019.100393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100393"}}